Sell, David

Follow Sell, David: Website |


Stock price rises for Merck with announcement of 8,500 layoffs

Stock price rises for Merck with announcement of 8,500 layoffs

October 2, 2013 1:11 pm by | 0 Comments

Merck & Co. made Wall Street happy but saddened employees Tuesday when the drug manufacturer said it would eliminate 8,500 jobs from its marketing, administrative, and research and development departments in the hope of reducing annual operating ex…


Remedi VP helped automate book delivery at Amazon, now he’s doing it for prescriptions

Remedi VP helped automate book delivery at Amazon, now he’s doing it for prescriptions

September 24, 2013 4:00 am by | 0 Comments

Jan Bohlmann earned a share in a patent while working as an engineer at Amazon.com. He helped make sure the right book went from a precise spot on a warehouse shelf, to a conveyor belt, to a box, to a truck, and to the right customer with the utmost ef…



Misinformation about vaccines places kids at risk

Misinformation about vaccines places kids at risk

September 16, 2013 12:34 pm by | 0 Comments

Most health-care professionals regret that some parents don’t vaccinate children because of now-debunked reports of vaccines causing autism.
The situation also drives Emilio Emini nuts. One of Pfizer Inc.’s top vaccine researchers, Emini often works fr…


What’s wrong with big pharma’s image? Pfizer CEO says it’s an issue of trust

What’s wrong with big pharma’s image? Pfizer CEO says it’s an issue of trust

September 12, 2013 1:51 pm by | 0 Comments

NEW YORK — Pharmaceutical companies have an image problem. Some seem to be starting to care more about it.
Pfizer Inc. collects more money from prescription drugs than any other company on the planet, with 2012 total revenue of $59 billion and net inc…


FDA issues guidance for generic version of GSK’s top-selling Advair

FDA issues guidance for generic version of GSK’s top-selling Advair

September 11, 2013 2:23 am by | 0 Comments

GlaxoSmithKline P.L.C.’s top-selling drug by far is the asthma medication Advair, which accounts for about 20 percent of company revenue, but generic competition got a bit closer to reality this week.
Advair is delivered to patients through an inhaler….


China may follow in U.S. footsteps, considers ‘astronomical’ fines for drugmakers

China may follow in U.S. footsteps, considers ‘astronomical’ fines for drugmakers

September 5, 2013 12:22 pm by | 0 Comments

Businesses are always looking for best practices to copy. Sometimes, governments do the same.
The Chinese government reportedly is considering emulating the U.S. government, whose investigations have resulted in billion-dollar penalties to pharmaceutic…


AstraZeneca to acquire Amplimmune, a biologics company focusing on cancer drugs

AstraZeneca to acquire Amplimmune, a biologics company focusing on cancer drugs

August 27, 2013 12:25 pm by | 0 Comments

Amgen’s $10.4 billion purchase of Onyx Pharmaceuticals for the sake of cancer drugs prompted much of Monday’s discussion in the pharmaceutical world, but AstraZeneca was also buying medicine in that category.
AstraZeneca, based in the United Kingdom bu…



J&J: Federal investigators questioning its opioid painkiller promotions

J&J: Federal investigators questioning its opioid painkiller promotions

August 7, 2013 4:10 pm by | 0 Comments

Johnson & Johnson has received a subpoena from federal investigators questioning how the drugmaker promotes its opioid painkiller Nucynta, the health-care giant said Friday in a filing with the Securities and Exchange Commission. Among the issues u…


For pharma CEO, a smaller pond, bigger waves

For pharma CEO, a smaller pond, bigger waves

July 29, 2013 12:15 pm by | 0 Comments

Before Maxine Gowen left the pharmaceutical giant GlaxoSmithKline in 2007, she was one of 103,000 employees in the company, and one of her jobs was to scout for small companies doing interesting research that might lead to new drugs and, perhaps, a cor…


Court’s decision in MS drug patent dispute spells trouble for Teva

Court’s decision in MS drug patent dispute spells trouble for Teva

July 28, 2013 8:50 am by | 0 Comments

Teva Pharmaceutical Industries Ltd. suffered a setback Friday when the U.S. Court of Appeals for the Federal Circuit in Washington ruled in favor of several generic companies in a patent dispute over Teva’s top-selling drug, Copaxone.
Copaxone is injec…


Women’s health groups unhappy that FDA granted Teva exclusive rights to Plan B One-Step

Women’s health groups unhappy that FDA granted Teva exclusive rights to Plan B One-Step

July 26, 2013 2:00 pm by | 0 Comments

The morning-after pill debate began anew this week when the U.S. Food and Drug Administration quietly said that Teva Pharmaceutical Industries Ltd. would have three years of exclusive rights to sell Plan B One-Step oral contraceptives to anyone of any …


Teva releases CEO pay and bonus details ($3.7M) to increase tranparency

Teva releases CEO pay and bonus details ($3.7M) to increase tranparency

July 19, 2013 4:00 am by | 0 Comments

Teva Pharmaceutical Industries Ltd.’s chief executive officer Jeremy Levin is in line to get $3.7 million in salary and bonuses attributable to 2012, pending a vote of shareholders in August of this year.
The company released information about Levin’s …


With a complete redesign and a new quality program, J&J hopes Fort Washington plant can reopen

With a complete redesign and a new quality program, J&J hopes Fort Washington plant can reopen

July 17, 2013 2:50 am by | 0 Comments

Johnson & Johnson’s top executives said Tuesday that they hope U.S. regulators will soon certify that their factory in Fort Washington is ready to resume making medicine. The McNeil Consumer…


As VP for global innovation, Wendy Mayer gives Pfizer employees tools to help them ‘be brave’

As VP for global innovation, Wendy Mayer gives Pfizer employees tools to help them ‘be brave’

July 12, 2013 4:59 pm by | 0 Comments

Almost every organization of any size says innovation is important, but many struggle to apply new ideas successfully.
Pfizer is the world’s top seller of prescription medicine, and some of its 85,000 employees work in Collegeville, Montgomery County. …


Lawyer says FDA ‘dragging its feet’ over concerns that J&J antipsychotic drugs are dangerous

Lawyer says FDA ‘dragging its feet’ over concerns that J&J antipsychotic drugs are dangerous

July 10, 2013 2:37 pm by | 0 Comments

The U.S. Food and Drug Administration is dragging its feet in addressing concerns that Johnson & Johnson’s antipsychotic drugs Risperdal and Invega are dangerous, a Philadelphia lawyer says in letters to the federal agency, and the company should a…